RxDoctor Payments Data

Sharon Hunt

Family · Mc Kees Rocks, PANPI 1518228469

Payments from drug & device makers

$3,564in general payments, 2019–2025

Across 170 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$521
  • Boehringer Ingelheim$414
  • AstraZeneca$362
  • E.r. Squibb & Sons, L.L.C.$358
  • Novartis$236
  • Heartflow, Inc.$208
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,564100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,564 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban355$278,054
XareltoRivaroxaban110$106,910
JardianceEmpagliflozin81$71,820
Repatha SureclickEvolocumab102$67,802
EntrestoSacubitril/Valsartan62$53,233
BrilintaTicagrelor35$18,072
MultaqDronedarone Hcl11$16,990
Repatha SyringeEvolocumab16$16,054
Praluent PenAlirocumab29$13,716
FarxigaDapagliflozin Propanediol21$11,707
Metoprolol Succinate407$4,627
Diltiazem 24hr Er (Cd)Diltiazem Hcl131$4,312
Atorvastatin Calcium372$3,983
Ranolazine ErRanolazine30$3,586
Carvedilol348$2,259

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$41$278,054355 claims
Johnson & JohnsonXarelto$521$106,910110 claims
Boehringer IngelheimJardiance$414$71,82081 claims
NovartisEntresto$236$53,23362 claims
AstraZenecaBrilinta, Farxiga$362$29,77956 claims
Sanofi-aventis U.S. LLCMultaq$54$16,99011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,717 family providers in Pennsylvania.

Other family in Mc Kees Rocks

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →